Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Jose Banchs

Concepts (224)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Echocardiography
14
2020
629
3.990
Why?
Heart Diseases
11
2020
372
2.750
Why?
Neoplasms
20
2020
1963
2.520
Why?
Echocardiography, Transesophageal
5
2019
134
1.490
Why?
Ventricular Function, Left
6
2020
454
1.370
Why?
Heart Ventricles
6
2018
723
1.340
Why?
Ventricular Dysfunction, Left
6
2020
379
1.240
Why?
Heart Neoplasms
3
2018
51
1.240
Why?
Cardiovascular Diseases
7
2020
1616
1.170
Why?
Anthracyclines
4
2019
30
1.150
Why?
Antineoplastic Agents
10
2019
2040
1.110
Why?
Medical Oncology
5
2020
168
0.920
Why?
Cardiology
4
2020
286
0.920
Why?
Stroke Volume
6
2020
496
0.900
Why?
Heart Function Tests
2
2019
77
0.830
Why?
Thrombosis
2
2018
244
0.780
Why?
Practice Patterns, Nurses'
1
2018
15
0.780
Why?
Osteosarcoma
1
2019
76
0.760
Why?
Sarcoma
2
2018
119
0.710
Why?
Thrombocytopenia
1
2019
175
0.710
Why?
Tachycardia, Sinus
1
2016
2
0.700
Why?
Diagnostic Imaging
3
2018
273
0.680
Why?
Pericardial Effusion
4
2019
17
0.680
Why?
Cardiomyopathies
2
2016
282
0.650
Why?
Echocardiography, Three-Dimensional
2
2018
74
0.620
Why?
Education, Medical, Continuing
1
2016
136
0.620
Why?
Recovery of Function
2
2016
590
0.620
Why?
Takotsubo Cardiomyopathy
1
2015
4
0.610
Why?
Pericarditis
1
2014
15
0.600
Why?
Fibroma
1
2014
13
0.600
Why?
Rural Population
1
2018
444
0.590
Why?
Aortic Aneurysm
1
2014
55
0.570
Why?
Radiation Injuries
1
2015
123
0.550
Why?
Radiotherapy
1
2015
203
0.540
Why?
Endocarditis
1
2012
34
0.510
Why?
Cardiovascular Infections
1
2012
3
0.500
Why?
Multimodal Imaging
4
2018
117
0.500
Why?
Vascular Diseases
1
2015
220
0.500
Why?
Heart Valve Prosthesis Implantation
1
2014
190
0.500
Why?
Tongue Neoplasms
1
2012
18
0.490
Why?
Tracheoesophageal Fistula
1
2011
26
0.480
Why?
Cardiotoxicity
5
2020
20
0.480
Why?
Cardiac Tamponade
3
2016
17
0.480
Why?
Myocarditis
1
2012
85
0.470
Why?
Mass Screening
1
2018
991
0.460
Why?
Humans
51
2020
108073
0.450
Why?
Fluoroscopy
1
2011
140
0.450
Why?
Radiography, Interventional
1
2011
106
0.440
Why?
Ultrasonography, Interventional
1
2011
130
0.440
Why?
Trastuzumab
5
2016
90
0.410
Why?
Quality Improvement
1
2016
865
0.400
Why?
Middle Aged
20
2019
28290
0.370
Why?
Stents
1
2011
392
0.370
Why?
Female
29
2019
61236
0.370
Why?
Echocardiography, Doppler, Color
3
2015
47
0.360
Why?
Male
26
2019
59744
0.360
Why?
Heart
3
2018
679
0.360
Why?
Early Diagnosis
3
2018
226
0.350
Why?
Carcinoma, Squamous Cell
1
2012
537
0.340
Why?
Breast Neoplasms
5
2015
1855
0.330
Why?
Esophageal Neoplasms
2
2020
225
0.310
Why?
Heart Conduction System
2
2015
91
0.300
Why?
Troponin I
3
2015
78
0.290
Why?
Prognosis
7
2019
3402
0.270
Why?
Lung Neoplasms
4
2020
2148
0.260
Why?
Antineoplastic Combined Chemotherapy Protocols
3
2019
1360
0.260
Why?
Fatal Outcome
2
2015
309
0.250
Why?
Electrocardiography
2
2015
659
0.240
Why?
Predictive Value of Tests
7
2018
1983
0.230
Why?
Radiation, Ionizing
1
2020
58
0.220
Why?
Atrial Fibrillation
2
2015
329
0.220
Why?
Ultrasonography
3
2015
751
0.220
Why?
Biomarkers
6
2016
3311
0.210
Why?
Retrospective Studies
10
2019
10506
0.210
Why?
Adult
13
2019
31195
0.200
Why?
Pericardiocentesis
1
2019
13
0.200
Why?
Erdheim-Chester Disease
1
2018
1
0.200
Why?
Carcinoma, Non-Small-Cell Lung
2
2020
935
0.200
Why?
Texas
3
2019
182
0.200
Why?
Systole
2
2016
195
0.200
Why?
Myxoma
1
2018
10
0.200
Why?
Radiotherapy, Intensity-Modulated
1
2020
162
0.200
Why?
Cardiac Imaging Techniques
1
2018
19
0.200
Why?
Coronary Artery Disease
2
2015
668
0.190
Why?
Aged
11
2018
19533
0.180
Why?
Carcinoid Heart Disease
1
2017
1
0.180
Why?
Echocardiography, Doppler
1
2018
129
0.180
Why?
Reproducibility of Results
3
2016
2806
0.180
Why?
Risk Factors
9
2020
8712
0.180
Why?
Doxorubicin
2
2015
304
0.170
Why?
Antineoplastic Agents, Immunological
1
2019
141
0.170
Why?
Academies and Institutes
1
2016
30
0.170
Why?
Multiple Myeloma
1
2018
123
0.170
Why?
Pericarditis, Constrictive
1
2016
8
0.170
Why?
Oligopeptides
1
2018
256
0.160
Why?
Cardiotoxins
1
2015
5
0.160
Why?
Antibodies, Monoclonal, Humanized
3
2015
605
0.160
Why?
Withholding Treatment
1
2016
66
0.160
Why?
Clinical Decision-Making
1
2018
255
0.160
Why?
Thrombolytic Therapy
1
2016
112
0.150
Why?
Follow-Up Studies
4
2019
4794
0.150
Why?
Cardiotonic Agents
1
2016
142
0.150
Why?
Myocardial Ischemia
1
2018
338
0.150
Why?
Ventricular Dysfunction
1
2015
18
0.150
Why?
Cefazolin
1
2014
9
0.150
Why?
ROC Curve
1
2016
481
0.150
Why?
Pulmonary Surgical Procedures
1
2014
9
0.150
Why?
Daptomycin
1
2014
16
0.150
Why?
Pericardium
1
2015
58
0.150
Why?
Carotid Artery Diseases
1
2015
63
0.150
Why?
Chemotherapy, Adjuvant
1
2015
301
0.140
Why?
Comorbidity
3
2019
1565
0.140
Why?
Pulmonary Embolism
1
2016
175
0.140
Why?
Dexmedetomidine
1
2014
66
0.140
Why?
Amyloidosis
1
2014
43
0.140
Why?
Heart Failure
2
2016
1788
0.140
Why?
Postoperative Complications
2
2015
2082
0.130
Why?
Preoperative Care
2
2015
357
0.130
Why?
Hodgkin Disease
1
2015
116
0.130
Why?
Heart Valve Prosthesis
1
2014
128
0.130
Why?
Peroxidase
1
2013
209
0.130
Why?
Cardiopulmonary Resuscitation
1
2016
220
0.130
Why?
Chemoradiotherapy
1
2014
200
0.130
Why?
Decision Trees
1
2012
76
0.130
Why?
Coronary Vessels
1
2015
263
0.130
Why?
Fluorodeoxyglucose F18
1
2013
146
0.130
Why?
Myocardium
1
2018
1087
0.120
Why?
Endocarditis, Bacterial
1
2012
31
0.120
Why?
Heart Arrest
1
2016
324
0.120
Why?
Radiopharmaceuticals
1
2013
212
0.120
Why?
Antibiotic Prophylaxis
1
2012
96
0.120
Why?
Young Adult
3
2019
10635
0.120
Why?
Positron-Emission Tomography
1
2013
305
0.120
Why?
Cardiac Catheterization
1
2015
536
0.110
Why?
Aortic Valve
1
2014
412
0.110
Why?
Prosthesis Implantation
1
2011
121
0.110
Why?
Radiosurgery
1
2013
362
0.100
Why?
Combined Modality Therapy
3
2018
1201
0.100
Why?
Risk Assessment
3
2018
3073
0.100
Why?
Anti-Inflammatory Agents
1
2012
441
0.100
Why?
Survival Rate
3
2019
1781
0.090
Why?
Sensitivity and Specificity
2
2011
1939
0.090
Why?
Treatment Outcome
4
2018
8857
0.090
Why?
Aged, 80 and over
4
2015
6648
0.090
Why?
Myocardial Infarction
1
2015
1073
0.090
Why?
Incidence
3
2020
2352
0.090
Why?
Antiviral Agents
1
2012
610
0.080
Why?
Palliative Care
1
2012
582
0.080
Why?
Prevalence
1
2011
2287
0.070
Why?
Natriuretic Peptide, Brain
2
2015
89
0.070
Why?
Anti-Bacterial Agents
1
2012
1250
0.070
Why?
Taxoids
2
2013
88
0.070
Why?
Adolescent
2
2019
18076
0.060
Why?
Mitral Valve Insufficiency
1
2001
65
0.060
Why?
Animals
3
2014
34482
0.060
Why?
United States
4
2019
11417
0.060
Why?
Poly-ADP-Ribose Binding Proteins
1
2019
25
0.050
Why?
DNA Topoisomerases, Type II
1
2019
52
0.050
Why?
Peptide Fragments
2
2015
702
0.050
Why?
Radiotherapy Dosage
1
2020
334
0.050
Why?
Societies
1
2018
40
0.050
Why?
Multivariate Analysis
2
2014
1598
0.050
Why?
Hemangiosarcoma
1
2018
20
0.050
Why?
Positron Emission Tomography Computed Tomography
1
2018
62
0.050
Why?
Logistic Models
2
2015
1975
0.050
Why?
DNA Damage
1
2020
355
0.050
Why?
Arterial Occlusive Diseases
1
2018
84
0.040
Why?
Cardiovascular System
1
2018
106
0.040
Why?
Interprofessional Relations
1
2019
261
0.040
Why?
Reference Values
1
2018
897
0.040
Why?
Morbidity
1
2017
244
0.040
Why?
Program Development
1
2019
380
0.040
Why?
Molecular Targeted Therapy
1
2019
379
0.040
Why?
Galectin 3
1
2015
15
0.040
Why?
Practice Guidelines as Topic
2
2014
1542
0.040
Why?
Growth Differentiation Factor 15
1
2015
28
0.040
Why?
Vascular Endothelial Growth Factor Receptor-1
1
2015
66
0.040
Why?
Recurrence
1
2018
974
0.040
Why?
Breast
1
2015
136
0.040
Why?
Diastole
1
2015
161
0.040
Why?
Adrenergic alpha-2 Receptor Agonists
1
2014
37
0.040
Why?
Intraoperative Care
1
2014
68
0.040
Why?
Global Health
1
2017
320
0.040
Why?
Program Evaluation
1
2019
834
0.040
Why?
SEER Program
1
2015
201
0.040
Why?
Biopsy
1
2018
1071
0.040
Why?
Ohio
1
2014
123
0.040
Why?
Secondary Prevention
1
2016
242
0.040
Why?
Clinical Trials, Phase I as Topic
1
2014
55
0.040
Why?
Europe
1
2014
345
0.030
Why?
Drug Monitoring
1
2015
217
0.030
Why?
Oxidative Stress
1
2020
1210
0.030
Why?
Amyloid
1
2014
80
0.030
Why?
Clinical Trials as Topic
1
2018
1007
0.030
Why?
C-Reactive Protein
1
2015
358
0.030
Why?
Acute Disease
1
2016
986
0.030
Why?
Consensus
1
2014
385
0.030
Why?
Interleukin-1 Receptor-Like 1 Protein
1
2012
26
0.030
Why?
Odds Ratio
1
2015
1034
0.030
Why?
North America
1
2012
271
0.030
Why?
Neoplasm Staging
1
2015
1208
0.030
Why?
Pilot Projects
1
2016
1382
0.030
Why?
Radiology
1
2014
187
0.030
Why?
Action Potentials
1
2015
476
0.030
Why?
Disease Management
1
2016
599
0.030
Why?
Kaplan-Meier Estimate
1
2014
864
0.030
Why?
Time Factors
2
2013
7090
0.030
Why?
Chi-Square Distribution
1
2012
570
0.030
Why?
Anesthesia
1
2014
226
0.030
Why?
Age Factors
1
2018
3275
0.030
Why?
Myocardial Contraction
1
2012
383
0.030
Why?
Societies, Medical
1
2014
757
0.030
Why?
Receptors, Cell Surface
1
2012
385
0.030
Why?
Patient Selection
1
2014
690
0.030
Why?
Longitudinal Studies
1
2015
2607
0.020
Why?
Magnetic Resonance Imaging
1
2018
2896
0.020
Why?
Cross-Sectional Studies
1
2015
3898
0.020
Why?
Cohort Studies
1
2013
4740
0.020
Why?
Prospective Studies
1
2012
5904
0.010
Why?
Mitral Valve
1
2001
109
0.010
Why?
Confidence Intervals
1
2001
339
0.010
Why?
Probability
1
2001
336
0.010
Why?
Observer Variation
1
2001
349
0.010
Why?
Severity of Illness Index
1
2001
2781
0.010
Why?
Banchs's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description

Copyright © 2021 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)